PKC-dependent phosphorylation of p27 at T198 contributes to p27 stabilization and cell cycle arrest

Cell Cycle

Volumn 11, Issue 8, 2012, Pages 1583-1592

  De Vita, Fernanda ^a   Riccardi, Miriam ^a,b   Malanga, Donatella ^a,b   Scrima, Marianna ^a,b   De Marco, Carmela ^a,b   Viglietto, Giuseppe ^a,b  

^a Grande Ospedale Metropolitano   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

p27; Phosphorylation; PKC; Stabilization; T198

Indexed keywords

PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN P27;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL STRAIN MCF 7; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

EID: 84860320308     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.20003     Document Type: Article

References (68)

1. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13:1501-12; PMID:10385618; http://dx.doi. org/10.1101/gad.13.12.1501.
2. Hengst L, Reed SI. Inhibitors of the Cip/Kip family. Curr Top Microbiol Immunol 1998; 227:25-41; PMID:9479824; http://dx.doi.org/10.1007/978-3-642- 71941-7-2.
3. Pines J. Cyclins and cyclin-dependent kinases: a biochemical view. Biochem J 1995; 308:697-711; PMID:8948422.
4. Nigg EA. Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 1995; 17:471-80; PMID:7575488; http://dx.doi.org/10.1002/bies.950170603.
5. Alessandrini A, Chiaur DS, Pagano M. Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation. Leukemia 1997; 11:342-5; PMID:9067571; http://dx.doi.org/10.1038/ sj.leu.2400581.
6. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78:59-66; PMID:8033212; http://dx.doi.org/10.1016/0092-8674(94)90572-X.
7. Ekholm SV, Reed SI. Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. Curr Opin Cell Biol 2000; 12:676-84; PMID:11063931; http:// dx.doi.org/10.1016/S0955-0674(00)00151-4.
8. Slingerland J, Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 2000; 183:10-7; PMID:10699961; http: //dx.doi.org/10.1002/(SICI)1097-4652(200004)183:1〈10::AID-JCP2〉3.0. CO;2-I.
9. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995; 269:682-5; PMID:7624798; http://dx.doi.org/10.1126/science.7624798.
10. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 1994; 372:570-3; PMID:7990932; http://dx.doi.org/10.1038/372570a0.
11. kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol Cell Biol 1996; 16:4327-36; PMID:8754833.
12. Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev Cell 2008; 14:159-69; PMID:18267085; http://dx.doi.org/10.1016/j. devcel.2008.01.013.
13. Kip1function in tumorigenesis. Genes Dev 2007; 21:1703-6; PMID:17639075; http://dx.doi.org/10. 1101/gad.1583207.
14. Kip1 metabolism: a fascinating labyrinth. Cell Cycle 2007; 6:1053-61; PMID:17426451; http:// dx.doi.org/10.4161/cc.6.9.4142.
15. Müller D, Bouchard C, Rudolph B, Steiner P, Stuckmann I, Saffrich R, et al. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes. Oncogene 1997; 15:2561-76; PMID:9399644; http://dx.doi.org/10.1038/sj.onc.1201440.
16. Kip1. Genes Dev 1997; 11:1464-78; PMID:9192873; http:// dx.doi.org/10.1101/gad.11.11.1464.
17. Vlach J, Hennecke S, Amati B. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J 1997; 16:5334-44; PMID:9311993; http://dx.doi.org/10.1093/emboj/16.17.5334.
18. Montagnoli A, Fiore F, Eytan E, Carrano AC, Draetta GF, Hershko A, et al. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev 1999; 13:1181-9; PMID:10323868; http://dx.doi.org/10.1101/gad.13.9.1181.
19. Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999; 1:193-9; PMID:10559916; http://dx.doi.org/10.1038/12013.
20. Kip1degradation and induces S phase in quiescent cells. Nat Cell Biol 1999; 1:207-14; PMID:10559918; http:// dx.doi.org/10.1038/12027.
21. Tsvetkov LM, Yeh KH, Lee SJ, Sun H, Zhang H. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol 1999; 9:661-4; PMID:10375532; http://dx.doi.org/10.1016/ S0960- 9822(99)80290-5.
22. Nakayama K, Nagahama H, Minamishima YA, Matsumoto M, Nakamichi I, Kitagawa K, et al. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J 2000; 19:2069- 81; PMID:10790373; http://dx.doi.org/10.1093/ emboj/19.9.2069.
23. Ganoth D, Bornstein G, Ko TK, Larsen B, Tyers M, Pagano M, et al. The cell cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. Nat Cell Biol 2001; 3:321-4; PMID:11231585; http://dx.doi.org/10.1038/35060126.
24. Kip1. Mol Cell 2001; 7:639-50; PMID:11463388; http://dx.doi.org/10.1016/S1097-2765(01)00210-6.
25. Kip1 promotes binding to 14-3-3 and cytoplasmic localization. J Biol Chem 2002; 277:28706-13; PMID:12042314; http://dx.doi.org/10.1074/jbc. M203668200.
26. kip1 in breast cancer. Cell Cycle 2004; 3:1074-80; PMID:15280662; http://dx.doi.org/10. 4161/cc.3.8.1073.
27. Kip1 at threonine 198 by p90 ribosomal protein S6 kinases promotes its binding to 14-3-3 and cytoplasmic localization. J Biol Chem 2003; 278:49254- 60; PMID:14504289; http://dx.doi.org/10.1074/jbc.M306614200.
28. Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M, et al. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 2007; 9:218-24; PMID:17237771; http://dx.doi. org/10.1038/ncb1537.
29. kip1. EMBO J 2006; 25:5159-70; PMID:17053782; http:// dx.doi.org/10.1038/sj.emboj.7601388.
30. Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 2004; 18:862-76; PMID:15078817; http://dx.doi.org/10.1101/ gad.1185504.
31. Nishizuka Y. Studies and perspectives of protein kinase C. Science 1986; 233:305-12; PMID:3014651; http:// dx.doi.org/10.1126/science.3014651.
32. Lévesque JT, Sirard MA. Effects of different kinases and phosphatases on nuclear and cytoplasmic maturation of bovine oocytes. Mol Reprod Dev 1995; 42:114-21; PMID:8562045; http://dx.doi.org/10.1002/mrd.1080420115.
33. Saxon ML, Zhao X, Black JD. Activation of protein kinase C isozymes is associated with post-mitotic events in intestinal epithelial cells in situ. J Cell Biol 1994; 126:747-63; PMID:8045938; http://dx.doi.org/10.1083/jcb.126.3. 747.
34. Spitaler M, Cantrell DA. Protein kinase C and beyond. Nat Immunol 2004; 5:785-90; PMID:15282562; http://dx.doi.org/10.1038/ni1097.
35. Shirai Y, Saito N. Activation mechanisms of protein kinase C: maturation, catalytic activation and targeting. J Biochem 2002; 132:663-8; PMID:12417013; http:// dx.doi.org/10.1093/oxfordjournals.jbchem.a003271.
36. Zhou FF, Xue Y, Chen GL, Yao X. GPS: a novel group-based phosphorylation predicting and scoring method. Biochem Biophys Res Commun 2004; 325:1443-8; PMID:15555589; http://dx.doi.org/10.1016/j.bbrc.2004.11.001.
37. Ballester R, Rosen OM. Fate of immunoprecipitable protein kinase C in GH3 cells treated with phorbol-12-myristate-13-acetate. J Biol Chem 1985; 260:15194-9; PMID:3905792.
38. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995; 9:484-96; PMID:7737456.
39. Kip1 for restriction point control of the fibroblast cell cycle. Science 1996; 272:877-80; PMID:8629023; http://dx.doi.org/10.1126/science.272. 5263.877.
40. 0 state) in fibroblasts. J Biol Chem 1996; 271:18337-41; PMID:8702474; http://dx.doi.org/10.1074/jbc.271.31.18337.
41. Kip1 stability, subcellular localization and tumor suppression. Genes Dev 2006; 20:47-64; PMID:16391232; http://dx.doi.org/10.1101/gad.1384406.
42. Kip1 is stabilized in G(0) by Mirk/dyrk1B kinase. J Biol Chem 2004; 279:22498-504; PMID:15010468; http://dx.doi.org/10.1074/jbc. M400479200.
43. Boehm M, Yoshimoto T, Crook MF, Nallamshetty S, True A, Nabel GJ, et al. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression. EMBO J 2002; 21:3390-401; PMID:12093740; http://dx.doi.org/10.1093/emboj/cdf343.
44. Batlle E, Verdú J, Domínguez D, del Mont Llosas M, Díaz V, Loukili N, et al. Protein kinase C-alpha activity inversely modulates invasion and growth of intestinal cells. J Biol Chem 1998; 273:15091- 8; PMID:9614119; http://dx.doi.org/10.1074/jbc.273.24.15091.
45. Abraham C, Scaglione-Sewell B, Skarosi SF, Qin W, Bissonnette M, Brasitus TA. Protein kinase C alpha modulates growth and differentiation in Caco-2 cells. Gastroenterology 1998; 114:503-9; PMID:9496940; http://dx.doi.org/10. 1016/S0016-5085(98)70533-5.
46. Kharait S, Dhir R, Lauffenburger D, Wells A. Protein kinase Cdelta signaling downstream of the EGF receptor mediates migration and invasiveness of prostate cancer cells. Biochem Biophys Res Commun 2006; 343:848-56; PMID:16564022; http://dx.doi.org/10.1016/j.bbrc.2006.03.044.
47. Haughian JM, Reno EM, Thorne AM, Bradford AP. Protein kinase C alpha-dependent signaling mediates endometrial cancer cell growth and tumorigenesis. Int J Cancer 2009; 125:2556-64; PMID:19672862; http:// dx.doi.org/10.1002/ijc.24633.
48. Margolis EJ, Choi JC, Shu WP, Liu BC. Specific sequences of fibronectin activate the protein kinase C signal transduction pathway in invasive bladder cancer. Cancer Lett 1996; 100:163-8; PMID:8620437; http:// dx.doi.org/10.1016/ 0304-3835(95)04096-X.
49. Wu TT, Hsieh YH, Wu CC, Hsieh YS, Huang CY, Liu JY. Overexpression of protein kinase C alpha mRNA in human hepatocellular carcinoma: a potential marker of disease prognosis. Clin Chim Acta 2007; 382:54-8; PMID:17459358; http://dx.doi.org/10.1016/j.cca.2007.03.018.
50. Weinstein IB. Nonmutagenic mechanisms in carcinogenesis: role of protein kinase C in signal transduction and growth control. Environ Health Perspect 1991; 93:175-9; PMID:1773790; http://dx.doi.org/10.1289/ehp.9193175.
51. McGarrity TJ, Peiffer LP. Protein kinase C activity as a potential marker for colorectal neoplasia. Dig Dis Sci 1994; 39:458-63; PMID:8131680; http://dx.doi.org/10.1007/BF02088328.
52. Kahl-Rainer P, Karner-Hanusch J, Weiss W, Marian B. Five of six protein kinase C isoenzymes present in normal mucosa show reduced protein levels during tumor development in the human colon. Carcinogenesis 1994; 15:779-82; PMID:8149496; http://dx.doi.org/10.1093/carcin/15.4.779.
53. Kahl-Rainer P, Sedivy R, Marian B. Protein kinase C tissue localization in human colonic tumors suggests a role for adenoma growth control. Gastroenterology 1996; 110:1753-9; PMID:8964400; http://dx.doi.org/10.1053/gast. 1996.v110.pm8964400.
54. Brasitus TA, Bissonnette M. PKC isoforms: villains in colon cancer? Gastroenterology 1998; 115:225-7; PMID:9649481; http://dx.doi.org/10.1016/S0016- 5085(98)70387-7.
55. Verstovsek G, Byrd A, Frey MR, Petrelli NJ, Black JD. Colonocyte differentiation is associated with increased expression and altered distribution of protein kinase C isozymes. Gastroenterology 1998; 115:75-85; PMID:9649461; http://dx.doi.org/10.1016/S0016-5085(98)70367-1.
56. Black JD. Protein kinase C isozymes in colon carcinogenesis: guilt by omission. Gastroenterology 2001; 120:1868-72; PMID:11375968; http://dx.doi.org/10.1053/gast.2001.25287.
57. Frey MR, Saxon ML, Zhao X, Rollins A, Evans SS, Black JD. Protein kinase C isozyme-mediated cell cycle arrest involves induction of p21(waf1/cip1) and p27(kip1) and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells. J Biol Chem 1997; 272:9424-35; PMID:9083081; http://dx.doi. org/10.1074/jbc.272.14.9424.
58. Frey MR, Clark JA, Leontieva O, Uronis JM, Black AR, Black JD. Protein kinase C signaling mediates a program of cell cycle withdrawal in the intestinal epithelium. J Cell Biol 2000; 151:763-78; PMID:11076962; http://dx.doi.org/10. 1083/jcb.151.4.763.
59. Clark JA, Black AR, Leontieva OV, Frey MR, Pysz MA, Kunneva L, et al. Involvement of the ERK signaling cascade in protein kinase C-mediated cell cycle arrest in intestinal epithelial cells. J Biol Chem 2004; 279:9233- 47; PMID:14670956; http://dx.doi.org/10.1074/jbc. M312268200.
60. 1 cyclin expression. J Biol Chem 1997; 272:13816-22; PMID:9153238; http://dx.doi.org/10.1074/jbc.272.21.13816.
61. Toyoda M, Gotoh N, Handa H, Shibuya M. Involvement of MAP kinase-independent protein kinase C signaling pathway in the EGF-induced p21(WAF1/Cip1) expression and growth inhibition of A431 cells. Biochem Biophys Res Commun 1998; 250:430-5; PMID:9753647; http://dx.doi.org/10.1006/bbrc.1998. 9332.
62. Ashton AW, Watanabe G, Albanese C, Harrington EO, Ware JA, Pestell RG. Protein kinase Cdelta inhibition of S-phase transition in capillary endothelial cells involves the cyclin-dependent kinase inhibitor p27(Kip1). J Biol Chem 1999; 274:20805-11; PMID:10409620; http:// dx.doi.org/10.1074/jbc.274.30.20805.
63. Shanmugam M, Krett NL, Maizels ET, Murad FM, Rosen ST, Hunzicker-Dunn M. A role for protein kinase Cdelta in the differential sensitivity of MCF-7 and MDA-MB 231 human breast cancer cells to phorbol ester-induced growth arrest and p21(WAFI/ CIP1) induction. Cancer Lett 2001; 172:43-53; PMID:11595128; http://dx.doi.org/10.1016/S0304- 3835(01)00602-4.
64. Page K, Li J, Corbit KC, Rumilla KM, Soh JW, Weinstein IB, et al. Regulation of airway smooth muscle cyclin D1 transcription by protein kinase C-delta. Am J Respir Cell Mol Biol 2002; 27:204-13; PMID:12151312.
65. Nakagawa M, Oliva JL, Kothapalli D, Fournier A, Assoian RK, Kazanietz MG. Phorbol ester-induced G1 phase arrest selectively mediated by protein kinase Cdelta-dependent induction of p21. J Biol Chem 2005; 280:33926-34; PMID:16055435; http://dx.doi. org/10.1074/jbc.M505748200.
66. Pysz MA, Leontieva OV, Bateman NW, Uronis JM, Curry KJ, Threadgill DW, et al. PKCalpha tumor suppression in the intestine is associated with transcriptional and translational inhibition of cyclin D1. Exp Cell Res 2009; 315:1415-28; PMID:19232344; http:// dx.doi.org/10.1016/j.yexcr.2009.02.002.
67. 1/S phase: evidence for an effect mediated by PKCdelta. Mol Cell Endocrinol 2008; 292:26-35; PMID:18541361; http://dx.doi.org/10.1016/j.mce.2008.04.018.
68. kip1 for embryonal carcinoma cell survival and differentiation. Oncogene 1999; 18:6241-51; PMID:10597222; http://dx.doi.org/10.1038/sj.onc.1203031.